![Jonas Wang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonas Wang
Direktor/Vorstandsmitglied bei
TWI BIOTECHNOLOGY, INC.
Profil
Jonas Wang is currently Chairman at StemCyte, Inc. since 2009 and at Stemcyte International Ltd. since 2022.
Holds the position of Director at Epitomics, Inc. Serves as Independent Director at TWi Biotechnology, Inc. since 2019.
Works as an Investment Professional at Sycamore Management Corp.
and at Sycamore Ventures Pte Ltd. since 2001.
Former roles include Associate Director-Basic Pharmaceutics at Bristol Myers Squibb Co., Director at U-Systems, Inc., and Vice President-Research & Technology at Johnson & Johnson.
Education includes graduate studies at the University of Iowa and undergraduate studies at National Defense Medical Center.
Aktive Positionen von Jonas Wang
| Unternehmen | Position | Beginn |
|---|---|---|
| TWI BIOTECHNOLOGY, INC. | Direktor/Vorstandsmitglied | 05.06.2019 |
Sycamore Ventures Pte Ltd.
 Sycamore Ventures Pte Ltd. Investment ManagersFinance Sycamore Ventures invests in companies located in the United States, India, and the Asia-Pacific region. The firm focuses on a broad range of sectors, including information technology, consumer, manufacturing, and media. It participates in later-stage capital requirements. | Private Equity Investor | 01.01.2001 |
Epitomics, Inc.
 Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody technology used for research and diagnostics | Direktor/Vorstandsmitglied | - |
Sycamore Management Corp.
 Sycamore Management Corp. Investment ManagersFinance Sycamore Ventures invests in late-stage information technology and bio-pharmaceutical companies with proven business models and management teams with strong execution capabilities. | Portfolio Manager-Aktien | - |
StemCyte, Inc.
 StemCyte, Inc. Medical/Nursing ServicesHealth Services Provides baby’s precious stem cells preservation services | Vorsitzender | 01.01.2009 |
Ehemalige bekannte Positionen von Jonas Wang
| Unternehmen | Position | Ende |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
U-Systems, Inc.
 U-Systems, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets ultrasound systems | Direktor/Vorstandsmitglied | - |
| JOHNSON & JOHNSON | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Jonas Wang
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
35
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
StemCyte, Inc.
StemCyte, Inc. Medical/Nursing ServicesHealth Services Provides baby’s precious stem cells preservation services | Health Services |
Epitomics, Inc.
Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody technology used for research and diagnostics | Health Technology |
Sycamore Management Corp.
Sycamore Management Corp. Investment ManagersFinance Sycamore Ventures invests in late-stage information technology and bio-pharmaceutical companies with proven business models and management teams with strong execution capabilities. | Finance |
Sycamore Ventures Pte Ltd.
Sycamore Ventures Pte Ltd. Investment ManagersFinance Sycamore Ventures invests in companies located in the United States, India, and the Asia-Pacific region. The firm focuses on a broad range of sectors, including information technology, consumer, manufacturing, and media. It participates in later-stage capital requirements. | Finance |
University of Iowa
 University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
U-Systems, Inc.
U-Systems, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets ultrasound systems | Health Technology |
National Defense Medical Center
 National Defense Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TWi Biotechnology, Inc.
 TWi Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops new drugs for unmet medical needs | Health Technology |
